SEHK:775Biotechs
CK Life Sciences Int'l. (Holdings) (SEHK:775) Loss Deepens Challenging Bullish Narratives
CK Life Sciences Int'l. (Holdings) (SEHK:775) has just reported its FY 2025 first half numbers, with revenue of HK$2,605.8 million and a basic EPS loss of HK$0.0157, while trailing twelve month figures show revenue of HK$5.4 billion and a basic EPS loss of HK$0.0194. Over the recent reported halves, the company has seen revenue move from HK$2,635.9 million in 1H 2024 to HK$2,886.8 million in 2H 2024 and then to HK$2,605.8 million in 1H 2025. This has come alongside a shift in basic EPS from...